Ana Gual-de-Torrella

ORCID: 0000-0003-0470-418X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antibiotic Resistance in Bacteria
  • Bacterial biofilms and quorum sensing
  • Bacterial Identification and Susceptibility Testing
  • Global Cancer Incidence and Screening
  • SARS-CoV-2 detection and testing
  • Infections and bacterial resistance
  • BRCA gene mutations in cancer
  • Biosensors and Analytical Detection
  • Antibiotic Use and Resistance
  • Antimicrobial agents and applications
  • Orthopedic Infections and Treatments
  • SARS-CoV-2 and COVID-19 Research
  • Pharmaceutical and Antibiotic Environmental Impacts
  • Breast Cancer Treatment Studies
  • Colorectal Cancer Screening and Detection
  • Legionella and Acanthamoeba research
  • Bacteriophages and microbial interactions
  • Cancer Risks and Factors
  • Colorectal Cancer Surgical Treatments
  • Ovarian cancer diagnosis and treatment
  • Liver Disease Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Breast Implant and Reconstruction
  • Multiple and Secondary Primary Cancers
  • Genetic factors in colorectal cancer

BioCruces Health research Institute
2023-2024

Hospital de Galdakao
2020-2024

Hospital Universitario Virgen Macarena
2018-2023

Organización Nacional de Trasplantes
2023

TIE Kinetix (Germany)
2023

Hospital Universitario 12 De Octubre
2023

Instituto de Biomedicina de Sevilla
2020-2022

Universidad de Sevilla
2020-2022

Instituto de Salud Carlos III
2021-2022

Red Espanola de Investigacion en Patologia Infecciosa
2021-2022

Juan Berenguer Antonio Rivero Inmaculada Jarrín M.J. Núñez María Jesús Vivancos and 95 more Manel Crespo María Jesús Téllez Peré Domingo José Antonio Iribarren Arturo Artero Manuel Márquez Ignacio de los Santos J. Marta Moreno Marta Montero Juan González‐García Leire Pérez‐Latorre Pilar Miralles J. C. Lopez F Parras B. Padilla Teresa Aldámiz A. Carrero Cristina Díez Francisco Tejerina Juan Berenguer M.J. Núñez Francisco Arnalich José Ramón Arribas José Ignacio Bernardino Juan González‐García Víctor Hontañón Luz Martín‐Carbonero Rocío Montejano Marisa Montes V. Moreno Ignacio Valero Carolina Navarro-San Francisco M.J. Núñez Eulalia Valencia Juan González‐García Francisca Cuenca Antonio Rivero Inmaculada Jarrín María Jesús Vivancos Santiago Moreno Ana Moreno José L. Casado Maria Jesús Pérez‐Elías Carmen Quereda Ana Gual-de-Torrella Jordi Navarro Natàlia Ramos Manuel Crespo M.E. Rodrigo Vicente Estrada Jorge Vergas María Jesús Téllez J. Muñoz M Gutiérrez Gràcia Mateo Josep M. Guardiola Peré Domingo Maialen Ibarguren M.P. Carmona Francisco Rodríguez-Arrondo Má Goenaga Harkaitz Azkune M. A. von Wichmann José Antonio Iribarren Jorge Carmena Arturo Artero Juan Pablo Ruíz Enrique Nuño Rosario Palacios José Ramón Santos Manuel Márquez José Sanz Ignacio de los Santos J.M. Ramírez-Moreno Piedad Arazo Marta Montero María Tasias S. Cuéllar Eva Muñoz Marino Blanes Jovita Fernández‐Pinero José López-Aldeguer Miguel Salavert Asunción Hernando Lourdes Domínguez Otilia Bisbal María Lagarde Mariano Matarranz Rafael Rubio Federico Pulido Coral García Carlos Armiñanzas S Echevarrı́a M. Gutiérrez-Cuadra Carmen Fariñas

Background. The purpose of this study was to assess the prevalence anti-hepatitis C virus (HCV) antibodies (Abs) and active HCV infection in human immunodeficiency (HIV)-infected (HIV+) patients Spain 2015. This a cross-sectional study. Methods. performed 41 centers Sample size estimated for an accuracy 2%, number from each hospital determined by proportional allocation, were selected using simple random sampling. Results. reference population 35 791 patients, sample 1867 patients. Hepatitis...

10.1093/ofid/ofw059 article EN cc-by-nc-nd Open Forum Infectious Diseases 2016-01-01

Survival for breast cancer (BC) is lower in eastern than northern/central Europe, and older younger women. We analysed how comorbidities at diagnosis affected whether selected standard treatments (STs) were given, across Europe over time, also assessing consequences survival/relapse. 7581 stage I/IIA cases diagnosed 9 European countries 2009–2013, 4 STs: surgery; breast‐conserving surgery plus radiotherapy (BCS + RT); reconstruction after mastectomy; prompt treatment (≤6 weeks diagnosis)....

10.1002/ijc.31974 article EN International Journal of Cancer 2018-11-09

Although the failure of antibiotic treatment is normally attributed to resistance, tolerance and persistence display a significant role in lack response antibiotics. Due fact that several nosocomial pathogens show high level and/or resistance chlorhexidine, this study we analyzed molecular mechanisms associated with chlorhexidine adaptation two clinical strains Klebsiella pneumoniae by phenotypic transcriptomic studies. These belong ST258-KPC3 (high-risk clone carrying β-lactamase KPC3)...

10.3390/toxins12090566 article EN cc-by Toxins 2020-09-02

Abstract The standard RT-PCR assay for COVID-19 is laborious and time-consuming, limiting the availability of testing. Rapid antigen-detection tests are faster less expensive; however, reliability these must be validated before they can used widely. objective this study was to determine Panbio TM Ag Test Device (PanbioRT) (Abbott) SARS-CoV-2 in nasopharyngeal swab specimens. This a prospective multicenter ten Spanish university hospitals patients from hospital units with clinical symptoms or...

10.1101/2020.11.18.20230375 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-11-20

Abstract: Breast cancer in young patients is relatively uncommon. There no consensus about the impact of age on prognosis. The aim this study was to analyze effect over risk recurrence breast using a population-registry database Spain. A retrospective case-control type designed. total 1,210 fulfilled inclusion criteria. cutoff at 40 years used define two groups patients: group A, ≤40 (n = 111); and B, >40 1,099). Younger women showed higher rate undifferentiated tumors; percentage positive...

10.1111/j.1524-4741.2011.01208.x article EN The Breast Journal 2011-12-30

To describe IMP-type carbapenemase-producing Pseudomonas aeruginosa outbreaks at Galdakao University Hospital between March 2021 to December 2021.Outbreak report.Galdakao is a tertiary-care hospital in the Basque Country (northern Spain).All patients with positive carbapenemase producing (IMP-PA) culture were included this study, both colonization and infection cases.An outbreak investigation was conducted, which molecular epidemiology analysis [pulsed-field gel electrophoresis whole-genome...

10.1017/ice.2023.75 article EN Infection Control and Hospital Epidemiology 2023-05-04

In 2014-2015, the main CTX-M-15- and OXA-48-producing clone in our region was ST15. Recently, K. pneumoniae ST15 isolates co-producing VIM-1 CTX-M-15 were detected several hospitals. The aim to study emergence acquisition of this carbapenemase. Between 2017 2019, four hospitals submitted twenty-nine VIM-1- CTX-M-15-producing laboratory. Seven representatives each XbaI PFGE pulsotype sequenced using short- long-read technologies. RAST, CGE databases, Pathogenwatch used for resistance...

10.3390/antibiotics12121727 article EN cc-by Antibiotics 2023-12-13

The rise of bacterial antimicrobial resistance (AMR) poses a significant challenge to modern medicine, with predictions suggesting it could become the leading cause death by 2050. interconnected nature our world, exemplified recent pandemics, highlights potential for rapid spread antibiotic-resistant bacteria, including carbapenemase-producing Enterobacteriaceae (CPE). In complex healthcare systems, introduction clonal CPE can lead multihospital outbreaks, necessitating characterization...

10.1099/acmi.0.000668.v1 preprint EN cc-by 2023-07-07
Coming Soon ...